To identify genes required for maintaining neuronal viability, we screened our collection of Drosophila temperature-sensitive paralytic mutants for those exhibiting shortened lifespan and neurodegeneration. Here, we describe the characterization of wasted away (wstd), a recessive, hypomorphic mutation that causes progressive motor impairment, vacuolar neuropathology, and severely reduced lifespan. We demonstrate that the affected gene encodes the glycolytic enzyme, triosephosphate isomerase (Tpi). Mutations causing Tpi deficiency in humans are also characterized by progressive neurological dysfunction, neurodegeneration, and early death. In Tpi-deficient flies and humans, a decrease in ATP levels did not appear to cause the observed phenotypes because ATP levels remained normal. We also found no genetic evidence that the mutant Drosophila Tpi was misfolded or involved in aberrant protein-protein associations. Instead, we favor the hypothesis that mutations in Tpi lead to an accumulation of methylglyoxal and the consequent enhanced production of advanced glycation end products, which are ultimately responsible for the death and dysfunction of Tpi-deficient neurons. Our results highlight an essential protective role of Tpi and support the idea that advanced glycation end products may also contribute to pathogenesis of other neurological disorders.
To identify genes required for maintaining neuronal viability, we screened our collection of Drosophila temperature-sensitive paralytic mutants for those exhibiting shortened lifespan and neurodegeneration. Here, we describe the characterization of wasted away (wstd), a recessive, hypomorphic mutation that causes progressive motor impairment, vacuolar neuropathology, and severely reduced lifespan. We demonstrate that the affected gene encodes the glycolytic enzyme, triosephosphate isomerase (Tpi). Mutations causing Tpi deficiency in humans are also characterized by progressive neurological dysfunction, neurodegeneration, and early death. In Tpi-deficient flies and humans, a decrease in ATP levels did not appear to cause the observed phenotypes because ATP levels remained normal. We also found no genetic evidence that the mutant Drosophila Tpi was misfolded or involved in aberrant protein-protein associations. Instead, we favor the hypothesis that mutations in Tpi lead to an accumulation of methylglyoxal and the consequent enhanced production of advanced glycation end products, which are ultimately responsible for the death and dysfunction of Tpi-deficient neurons. Our results highlight an essential protective role of Tpi and support the idea that advanced glycation end products may also contribute to pathogenesis of other neurological disorders.
advanced glycation end product F orward genetic strategies in Drosophila have proven to be a powerful approach for dissecting the molecular mechanisms of neuronal signaling. Unbiased screens for mutants based solely on phenotype enabled the molecular identification and characterization of proteins with key roles in neuronal function that were previously unknown or inaccessible via alternative approaches. The phenotype of temperature-sensitive (ts) paralysis has been particularly potent for discovering genes with crucial roles in neural function (1) (2) (3) . Over the years, we have amassed a large collection of ts-paralytic mutations and discovered among them genes encoding a variety of ion channels, ion channel regulators, components of the synaptic release machinery, and proteins required for synaptic growth.
One of the important insights derived from investigating these mutants is that in most cases their conditional phenotype is not caused by the temperature sensitivity of the mutant proteins (4) (5) (6) (7) (8) . Instead, most of the mutations cause unconditional complete or partial loss of activity of the affected proteins, resulting in varying degrees of neural impairment even at nominally permissive temperatures. At permissive temperatures, these impairments are generally not sufficient to cause drastic deficits in locomotor activity or other behaviors. However, when neural function is impaired for any of a variety of reasons, the mutant flies apparently cannot withstand the greater physiological demands of elevated temperature and become paralyzed within seconds to minutes.
Recently, a number of investigators have used the experimental advantages of Drosophila to model human neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, and triplet repeat disorders (reviewed in ref. 9) . Most of these studies have relied on existing knowledge to introduce human disease genes into flies or target the Drosophila counterpart of these genes for experimental manipulation to create flies with phenotypes that mimic the human syndromes. A more open-ended strategy to investigate the basic biology of neurodegeneration is to use a forward genetics approach to identify a collection of genes whose function is necessary to ensure neuronal maintenance and survival. Isolation and characterization of such ''neurodegeneration suppressor'' genes should provide important insights into the molecular mechanisms that maintain neuronal viability. Although several studies have focused on forward genetic screens for neurodegeneration in Drosophila, the number of mutations identified in this way still remains relatively small (10) (11) (12) (13) (14) (15) (16) .
We reasoned that our collection of ts-paralytic mutants, originally isolated because they exhibited aberrant behaviors likely to be associated with altered or impaired neural function, included those whose behavioral deficits were associated with neurodegeneration. For example, some of the mutants showed progressive motor impairments even at permissive temperature as a function of age. Indeed, an initial histological survey of our collection demonstrated that it was enriched for mutants with defects in neuronal survival: Ϸ10% of the mutants examined manifest varying degrees of age-dependent neuropathology in the central nervous system (17) . Among the previously identified mutants associated with neurodegeneration are those encoding ion channels, the Na ϩ ͞K ϩ ATPase, and components of the synaptic release machinery (17) (18) (19) .
Here, we demonstrate that one of the previously uncharacterized mutations disrupts the gene encoding the glycolytic enzyme, triosephosphate isomerase (Tpi), resulting in progressive motor impairment, severely reduced lifespan, and neurodegeneration. These phenotypes closely resemble those associated with triosephosphate deficiency in humans (20, 21) . Thus, even though our initial mutant screen did not specifically target human disease genes, we have obtained an excellent Drosophila model for a human neurodegenerative disorder. Our results indicate that the neurological phenotypes do not result simply from a reduction in ATP production. Nor do we have any genetic evidence of aberrant protein misfolding or inappropriate asso-ciations in wstd mutants. Instead, we favor the idea that loss of Tpi activity, which interconverts dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (GAP), results in elevated levels of DHAP. DHAP, in turn, spontaneously converts to methylglyoxal, a highly reactive compound that modifies proteins and DNA through the formation of advanced glycation end products (AGEs), which are deleterious to neurons and other cells (22) (23) (24) (25) . We contend that enhanced AGE production is responsible for the dysfunction and death of Tpi-deficient neurons (26) . Our results highlight an essential protective role of Tpi and underscore the possibility that AGEs contribute to pathogenesis of other neurological disorders as well.
Results
ts Paralysis and Shortened Lifespan in wstd Mutants. wstd 1 was isolated Ͼ25 years ago, in a large-scale screen for ts-paralytic mutants (B.G., unpublished work). It was selected for further investigation based on an initial survey of our ts-paralytic collection for neurodegeneration mutants (17) . At 22°C, wstd 1 homozygotes exhibit essentially normal locomotor activity. However, when shifted abruptly to 38°C, the mutants lose motor control and fall to the bottom of the vial within 1 min with occasional spasmodic activity and leg twitching. Paralysis becomes complete within 3-5 min at the elevated temperature. In contrast, WT and wstd 1 ͞ϩ f lies remain active at 38°C for Ͼ30 min.
Paralytic behavior of wstd 1 homozygotes at 38°C varied as a function of age (Fig. 1A) . Within the first day after eclosion, only Ϸ10% of mutant adults were paralyzed after a 2-min exposure to 38°C. This fraction increased to Ͼ90% for 6-day-old flies ( Fig.  1 A) . The time required for 100% of the flies to become paralyzed decreased from Ͼ10 min for 1-day-old wstd 1 flies to 4 min for 7-day-old flies to Ϸ1 min for 14-day-old flies (data not shown).
Kinetics of recovery from paralysis show the converse age dependence (Fig. 1B) . After a 10-min exposure to 38°C, 50% of flies that were Ͻ1 day posteclosion recover the ability to stand almost immediately upon return to room temperature. This time increased to Ͼ3.3 min for 2-day-old flies and 7.4 min for 6-day-old flies ( Fig. 1B) . After 3 weeks of age, wstd 1 flies required upwards of 30 min to recover from paralysis.
Lifespan measurements revealed that wstd 1 mutants are shortlived compared with WT controls and that this difference is accentuated at elevated temperatures ( Fig. 2) . At 22°C, wstd 1 flies reach the midpoint of their survival curve (T 50 ) in 41.4 Ϯ 2.8 days, compared with 54 Ϯ 0.88 days for controls (P Ͻ 0.001). At 29°C, the lifespan of wstd 1 flies is dramatically reduced with a T 50 of only 4.08 Ϯ 0.2 days, Ϸ10 times less than for control flies (38 Ϯ 4) at this temperature (P Ͻ 0.001). We infer that wstd 1 mutants have some underlying physiological impairment that results in reduced lifespan, even at temperatures below the threshold for causing paralysis.
Identification of Additional Mutant Alleles of wstd. Because we had just one mutant allele of wstd in our possession and wanted to be certain of obtaining a null allele, we conducted a failure of complementation screen for new alleles after ␥-ray mutagenesis. Treated males were mated with homozygous wstd 1 females, and the F 1 progeny were screened for paralysis at 38°C. We recovered one lethal allele (wstd 2 ) that failed to complement all wstd 1 phenotypes, including ts paralysis, shortened lifespan, and neurodegeneration. We identified two additional alleles (wstd 3 and wstd 4 ) by testing a previously generated set of ethylmethane sulfonate-induced lethal alleles in the vicinity of wstd for failure to complement (27) . The three new alleles are lethal in all heterozygous combinations with each other and when heterozygous for Df(3R)Exel6214, a deletion that completely uncovers the wstd gene. Flies heterozygous for wstd 1 and any of the lethal alleles exhibit more extreme mutant phenotypes than wstd 1 homozygotes and are comparable in severity to flies heterozygous for wstd 1 and Df(3R)Exel6214. These results indicate that the original wstd 1 mutation is a hypomorphic allele and that the lethal mutations represent the null phenotype. In addition, the failure of three different lethal alleles to complement all phenotypes associated with wstd strongly implies that all phenotypes result from mutations of the same single gene.
wstd Causes Progressive, Age-Dependent Neurodegeneration. Histological examination of frontal head sections of wstd 1 homozygotes incubated for 1-4 days at 29°C demonstrated the presence of characteristic neurodegenerative vacuolar lesions in the neuropil of the central brain that become more pronounced and extensive with age (Fig. 3) . Immediately after shifting to 29°C, brains of wstd 1 flies are indistinguishable from normal (data not shown). After 1 day at 29°C neuropathological lesions, evident as small, scattered holes in the neuropil of the central brain, begin to appear and increase in number over the next several days (Fig. 3 B1, B2, C1, C2, F1, and F2) . Although lesions could be found throughout the brain in different individuals, they occurred most often in the neuropil lateral to the ellipsoid body and in the outer margin of the optic lobe (Fig. 3 B1, B2, F1, and  F2) . Even single lesions of this type were rare in WT flies (Fig.  3 A1 and A2) . The range of severity in the appearance of lesions in wstd flies varied. A small percentage of mutant brains exhibited a severe spongiform appearance (Fig. 3 C1 and C2) , whereas others had only sporadic lesions. Among Ͼ50 wstd brains examined, at least 75% could readily be distinguished from WT controls by their neuropathological appearance. Overall, flies heterozygous for wstd 1 and any of the null alleles exhibited more extreme neurodegeneration; only Ϸ10% of these brains overlapped control brains in appearance.
Molecular Identification of wstd. By recombination, wstd mapped to 3-100.0 Ϯ 3, to the right of the marker Dr, which is located at 99B2 on the cytological map. To refine the cytological location of wstd, we performed complementation tests with deletions that spanned the distal tip of the chromosome. Df(3R)Exel6214, deleted for 99D5-99E2, uncovered the ts-paralytic phenotype of wstd 1 . Dp(3;1)67A, an insertional duplication of 99D9-E1;100 into the X chromosome, did not complement wstd 1 , indicating that the duplication does not include wstd ϩ . Because the left endpoint of Dp(3;1)67A includes the myosin light chain-2 (Mlc2) gene (27) , wstd is located to the left of this gene (Fig. 4) . These results placed wstd in the interval, 99D5;99D9-E1 (Fig. 4) . The chromosome segment that includes wstd encompasses Ϸ50 kb on the molecular map and contains 10 genes, most of unknown function. We initiated sequence analysis of these genes and discovered coding changes in all four wstd alleles in the gene that encodes Tpi, an essential glycolytic enzyme that is highly con- served from bacteria to humans. Two wstd alleles introduce premature stop codons and two produce single amino acid changes. (Fig. 4) . The presence of mutational changes in Tpi in four different wstd alleles strongly indicates that this enzyme is the wstd gene product.
To verify that Tpi is the affected gene, we performed germline transformation rescue experiments with a genomic clone containing the entire WT wstd gene expressed from its endogenous promoter (P{Tpi ϩ }). Flies homozygous for wstd 1 and carrying one copy of the rescue construct were indistinguishable from WT flies with respect to locomotor behavior (0% paralysis after 20 min at 38°C), lifespan (100% survival after 21 days at 29°C), and neuronal survival (Fig. 3 D1 and D2 ). In addition, one copy of P{Tpi ϩ } rescued the lethal phenotype of wstd 2 , wstd 3 , and wstd 4 . Thus, P{Tpi ϩ } fully rescues all phenotypes associated with wstd mutations and establishes that all wstd phenotypes arise from mutations of Tpi.
wstd Does Not Cause Significant Reduction in ATP Levels. Mutations of Tpi in humans also result in neurodegenerative disease (20, 21) . However, the mechanism underlying the pathology of Tpi deficiency remains unclear. Because Tpi is an essential glycolytic enzyme and we have previously found that metabolic disruptions are associated with neurodegeneration in other Drosophila mutants, it seemed possible that a metabolic impairment resulting in reduced ATP levels could underlie the wstd mutant phenotypes. To test this possibility, we performed quantitative ATP assays. Although ATP levels are slightly lower in wstd homozygotes compared with WT controls, this difference was not significant (P Ͼ 0.37; Fig. 5 ). This result is consistent with human studies, which found no decrease in ATP levels in TPI-deficient patients (21, 28) . Thus, in flies, as in humans, a deficit in ATP is not the apparent cause of the neuropathological phenotypes associated with loss of Tpi activity. Instead, as described in Discussion, we favor the model that neuropathogenesis in flies and people deficient for Tpi activity results from accumulation of toxic metabolites upstream of the enzymatic block.
Discussion
Mutations of Tpi Cause Neurological Disease in Flies and Humans. In this study, we have identified mutations in the Drosophila gene that encodes the glycolytic enzyme, Tpi, on the basis of a forward genetic screen for neurodegeneration mutants. Mutations of the corresponding gene in humans cause the disorder, Tpi deficiency, which is associated with phenotypic manifestations similar to those seen in Drosophila, including hemolytic anemia, progressive neurologic dysfunction, neurodegeneration, and early death (20, 21) . Neurological symptoms first appear at 6 months to 2 years of age and involve lower motor neurons combined with dystonic and dyskinetic features of central origin. Death generally occurs by 6 years of age (21, 28) . Although TPI deficiency was first described in 1965, the underlying pathophysiology has remained elusive. The additional information derived from analysis of the Drosophila mutants offers insights into the underlying disease mechanism.
Several lines of evidence argue against the most obvious possibility, that the neurological phenotypes result from a metabolic impairment and a consequent deficit of ATP. First, quantitative assays both in humans and flies indicate there is no decrement in ATP levels when Tpi activity is impaired (21, 28) . Second, mutations affecting other glycolytic enzymes do not cause comparable neurological phenotypes. Mutations have been identified in humans that perturb most steps in glycolysis (28) . All of these mutations are associated with hemolytic anemia but, with the exception of phosphoglycerate kinase (PGK), none of the other enzymopathies cause neurological impairment even though several of them do cause significant reductions in ATP levels (28) . Thus, the mechanism by which Tpi deficiency leads to neurodegeneration appears to be distinct and not just a direct consequence of impaired glycolysis. We discuss later a possible mechanistic link between TPI deficiency and PGK deficiency.
Studies of several human TPI patients have led to the proposal that neurodegeneration is associated with misfolding and aberrant or inappropriate protein-protein associations of the mutant enzyme (29) (30) (31) . Although we cannot rule out this possibility in humans, it does not appear to be a key factor in Drosophila. The original wstd allele behaves as a fully recessive, hypomorphic mutation whose associated phenotypes are more extreme in flies heterozygous for wstd and a lethal null allele or a deletion of the gene than in wstd homozygotes. In addition, expression of a transgene containing a WT copy of the gene fully rescues all wstd phenotypes. Thus, we see no indication of dominant neomorphic or other gain-of-function phenotypes as would be expected if the mutant protein engages in aberrant or inappropriate associations with other cellular targets.
A Proposed Disease Mechanism for Tpi Deficiency. What is the basis of neurodegeneration in Tpi-deficient flies and humans if not a deficit in metabolism or a result of aberrant protein-protein associations? We favor the following model (Fig. 6) , which is based on the available information for Tpi mutations in flies and humans together with the growing body of data about methylglyoxal and its biological effects (22) (23) (24) (25) (26) . In glycolysis, fructose bisphosphate is broken down into GAP and DHAP. The glycolytic pathway can further metabolize only GAP. Tpi interconverts DHAP and GAP, enabling DHAP to be metabolically used (Fig. 6) . Loss of Tpi activity should therefore result in excess accumulation of DHAP. Indeed, the most apparent biochemical alteration reported in TPI-deficient patients is the striking (Ͼ20-fold) increase in cellular concentration of DHAP (21, 28) . Although there is no indication that DHAP itself is toxic, it decomposes nonenzymatically to methylglyoxal (23, 25) . Methylglyoxal is a highly reactive ␣-oxoaldehyde that can modify both proteins and DNA to form AGEs (22) (23) (24) (25) . The deleterious consequences of accumulated of glycation adducts include protein inactivation, denaturation, and crosslinking; altered gene expression; increased oxidative stress; DNA damage; and apoptosis. In humans, methylglyoxal and AGEs have been linked with a variety of conditions, including diabetes, uremia, cancer, and aging. Most important with respect to the phenotypes under consideration here, methylglyoxal is toxic to neurons (24, 32, 33) .
Normally the glyoxalase pathway protects cells from excess methylglyoxal (34) . Glyoxalase I and II detoxify methylglyoxal by converting it to lactic acid, using catalytic amounts of glutathione as a cofactor. However, under conditions of oxidative stress, glutathione levels are reduced, resulting in elevated levels of methylglyoxal. This effect can be further magnified in a positive feedback loop because AGEs themselves contribute to the production of reactive oxygen species (26) .
On the basis of these considerations, we suggest that the defects in the function and survival of Tpi-deficient neurons result from the toxic effects of elevated methylglyoxal levels. In the case of wstd mutants, we expect that reduction in Tpi activity causes methylglyoxal and AGEs to be elevated even at permissive temperatures. We propose that the affected targets include one or more proteins essential for neural activity and that AGE modifications compromise signaling capabilities of mutant neurons. As with other tsparalytic mutants that directly affect membrane excitability and synaptic transmission, under nonstressful conditions neurons in wstd mutants function sufficiently well that behavior is overtly normal. However, the weakened neurons are not able to withstand the greater physiological demands of elevated temperature, resulting in paralysis of wstd flies at 38°C. Chronic exposure to the intermediate temperature of 29°C results in accelerated neuronal death and shortened lifespan.
A similar mechanism may explain, in part, the neurological phenotypes associated with PGK deficiency. Although generally less severe than TPI deficiency, PGK deficiency results in exercise intolerance, seizures, mental retardation, and progressive extrapyramidal tract disease (28) . Interestingly, PGK mutations in Drosophila were also identified as ts-paralytic mutants (35) . It is not yet known whether these flies exhibit neurodegeneration, although they have a very reduced lifespan. The basis of the neurological phenotypes of PGK-deficient flies and humans is not known. Because PGK acts two steps downstream from Tpi (Fig. 6) , a block in PGK could be predicted to cause an accumulation of GAP and Loss of TPI activity (red) causes accumulation of excess DHAP, which converts to methylglyoxal nonenzymatically. Elevated methylglyoxal levels result in production of AGEs that impair neuronal function and survival. Methylglyoxal is normally detoxified by the glyoxalase pathway (green). Glyoxalase I (GloI) and glyoxalase II (GloII) use glutathione (GSH) as a cofactor to convert methylglyoxal to D-lactate.
